Dow Jones closes 0.31% lower at 51,886.10 amid mixed trading
- Dow Jones Industrial Average fell 0.31% to close at 51,886.10
- Index dropped 162.73 points during Tuesday's session
- Nasdaq Composite climbed 0.51% to 27,259.09
- S&P 500 rose 0.10% to 7,772.79
*this image is generated using AI for illustrative purposes only.
U.S. stocks traded mixed on Tuesday, with the Nasdaq Composite climbing 0.51% to 27,259.09, while the S&P 500 rose 0.10% to 7,772.79.
Dow Jones slips despite tech gains
The Dow Jones Industrial Average fell 0.31% to close at 51,886.10, a decline of 162.73 points. This move contrasts with the gains seen in the technology-heavy Nasdaq and the broader S&P 500 index.
Thor Industries leads headlines after Q4 results
Shares of Thor Industries rose around 5% on Tuesday after the company reported its fourth-quarter results. The company posted quarterly earnings of 78 cents per share, missing the analyst consensus estimate of 96 cents per share. Quarterly sales of $2.312 billion beat the analyst consensus estimate of $2.168 billion.
Sector performance
Communication services shares led gains, rising 1.2% on Tuesday. Financial stocks were the laggard, falling 2%.
Equities on the move
Several stocks saw sharp moves on Tuesday. The following companies recorded notable gains:
| Company | Move | Price | Catalyst |
|---|---|---|---|
| Viking Therapeutics Inc | +26% | $37.88 | Top-line results from maintenance study of VK2735 |
| Decoy Therapeutics Inc | +144% | $6.24 | Refined corporate strategy to explore D-MAVs for additional candidates |
| Quanome Technologies, Inc | +72% | $1.10 | Purchase and Sale Agreement with Compal Electronics for 32 GPU server units |
On the downside, several stocks declined sharply:
| Company | Move | Price | Catalyst |
|---|---|---|---|
| Celldex Therapeutics Inc | -15% | $32.18 | Topline results from Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 trials for barzolvolimab in chronic spontaneous urticaria |
| Compass Therapeutics Inc. | -25% | $1.36 | FDA recommended a survival benefit trial before a Biologics License Application for tovecimig in biliary tract cancer |
| Xanadu Quantum Technologies Ltd | -17% | $6.08 | No specific catalyst disclosed |
Commodities
Oil fell 1.4% to $94.45, while gold traded down 0.3% at $4,369.80. Silver declined 0.1% to $66.345, while copper rose 1.4% to $6.8595.
Global markets
European shares closed higher. The eurozone's STOXX 600 climbed 0.4%; Spain's IBEX 35 Index rose 0.7%; Germany's DAX gained 0.2%; France's CAC 40 rose 0.4%; and London's FTSE 100 slipped 0.1%.
Asian markets closed mixed on Tuesday. Hong Kong's Hang Seng index rose 0.18%, China's Shanghai Composite gained 0.06%, and India's BSE Sensex fell 0.44%.
Economic data
- The U.S. Redbook Index rose 7.6% year-over-year in the week ending Sept. 19.
- The Federal Reserve's Fifth District manufacturing index declined to -2 in September, compared to 4 in the previous month, versus market estimates of 5.
How might the divergence between the Dow Jones decline and Nasdaq gains signal a shift in investor preference toward growth stocks over value sectors?
What are the potential long-term revenue implications for Quanome Technologies following its GPU server purchase agreement with Compal Electronics?
Could the significant drop in financial sector performance indicate emerging concerns about interest rate trajectories or banking stability?
19
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
